Also liked the update on Clinical, potentially total of $200k+ in ARR for CY21 YTD not announced to market until now due to size of individual deals. Also encouraging to see the full Clinical opportunity updated from earlier presentations after someone identified this (previously 5% penetration was only presented as $0.9m):